APMD:NASDAQ, Apnimed Inc.

APMD stock overview

Apnimed Inc. (APMD:NASDAQ) closed at $16.09 on November 20, 2026, down 6.70% on the day. The stock trades 54.4% below its 52-week high of $35.29 and 15.9% above its 52-week low of $13.88. Over the past year, it lost 35.6%. Apnimed Inc. is part of the Health Care sector.

Key figures

Price
$16.09
Day change
-6.70%
Volume
248,586
Average volume
458,531
Market cap
669M+
52-week range
$13.88 – $35.29
50-day average
$19.67
200-day average
$22.72

Price action over the past year

In 79 trading sessions since August 3, 2026, APMD closed higher on 38 days (48%). Its best day was October 20, 2026 (+11.51%) and its worst was October 6, 2026 (-14.25%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

APMD news

About Apnimed Inc.

Apnimed is a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. We believe the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with obstructive sleep apnea (OSA). We believe that people with OSA would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of OSA's disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment and help more people get the oxygen and restorative sleep needed to thrive.

Similar stocks

Find more stocks like APMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.